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The translational activation of several maternal mRNAs in Xenopus laevis is dependent on cytoplasmic
poly(A) elongation. Messages harboring the UUUUUAU-type cytoplasmic polyadenylation element (CPE) in
their 3* untranslated regions (UTRs) undergo polyadenylation and translation during oocyte maturation. This
CPE is bound by the protein CPEB, which is essential for polyadenylation. mRNAs that have the poly(U)12–27
embryonic-type CPE (eCPE) in their 3* UTRs undergo polyadenylation and translation during the early
cleavage and blastula stages. A 36-kDa eCPE-binding protein in oocytes and embryos has been identified by UV
cross-linking. We now report that this 36-kDa protein is ElrA, a member of the ELAV family of RNA-binding
proteins. The proteins are identical in size, antibody directed against ElrA immunoprecipitates the 36-kDa
protein, and the two proteins have the same RNA binding specificity in vitro. Cl2 and activin receptor mRNAs,
both of which contain eCPEs, are detected in immunoprecipitated ElrA-mRNP complexes from eggs and
embryos. In addition, this in vivo interaction requires the eCPE. Although a number of experiments failed to
define a role for ElrA in cytoplasmic polyadenylation, the expression of a dominant negative ElrA protein in
embryos results in an exogastrulation phenotype. The possible functions of ElrA in gastrulation are discussed.
Early development in many animals is programmed by
mRNAs inherited by the egg at the time of fertilization. While
many of these mRNAs are translationally dormant in oocytes,
they become activated in a sequence-specific manner at sub-
sequent developmental periods. Several mechanisms are likely
to control the translation of these messages, but one that has
been studied extensively in Xenopus laevis is poly(A) elonga-
tion (31). Some mRNAs, which encode such proteins as c-Mos,
cyclin B1, cyclin-dependent kinase 2 (Cdk2), and the early-
development-specific histone B4, are polyadenylated and trans-
lated during oocyte maturation (27–29, 33, 39). Other mRNAs,
however, undergo these processes sometime after fertilization;
they encode such proteins as polypeptide chain release factor
(Cl1), Cl2 (function unknown), and activin receptor (28, 34–
36).
Both groups of mRNAs contain two cis-acting elements lo-
cated in their 39 untranslated regions (UTRs) that are required
for cytoplasmic polyadenylation. One is the virtually ubiqui-
tous hexanucleotide AAUAAA, which is also important for
nuclear pre-mRNA cleavage and polyadenylation. The second,
called the cytoplasmic polyadenylation element (CPE), is a
U-rich sequence located upstream of the hexanucleotide. The
exact sequence of CPE differs between the two groups of
mRNAs mentioned. The maturation-type CPE is UUUUUAU
(consensus), whereas the embryonic CPE (eCPE) is oligo
(U)12–27 (reviewed in reference 31). At least two mRNAs that
are polyadenylated in embryos also contain a third cis-acting
sequence in the 39 UTR: the masking element that prevents
precocious polyadenylation during maturation (34, 35). Be-
cause deletion of the masking element results in premature
polyadenylation during oocyte maturation, it is likely that the
factors that support embryonic polyadenylation are present
and active in maturing oocytes. In studies to identify these
factors, UV cross-linking in egg extracts has shown that the 36-
and 45-kDa proteins bind to the eCPE (34); however, only the
36-kDa protein is cytoplasmic and, based on parallel competi-
tion assays for both UV cross-linking and polyadenylation,
appeared to be functionally important for embryonic polyad-
enylation (36).
The products of Xenopus ELGs (embryonic lethal abnormal
vision [ELAV]-like genes) are similar to Drosophila ELAV and
other members of this family in that they contain a short
amino-terminal domain followed by two consecutive RNA rec-
ognition motifs (RRMs), a linker region, and a carboxyl-ter-
minal RRM (32). There are four ELG proteins in Xenopus,
named ElrA, ElrB, ElrC, and ElrD, with molecular masses
ranging from 36 to 42 kDa (10). The RRMs are highly con-
served among ElrB, -C, and -D; the RRMs for ElrA are less
well conserved. In addition, ElrA has shorter amino-terminal
and linker regions. By Northern analysis, ElrA appears to be
expressed ubiquitously, ElrB is expressed in both maternal and
brain tissues, whereas ElrC and -D have a brain-specific ex-
pression pattern (10). The ElrA sequence and expression pat-
tern are also conserved in mammals (22, 26). Members of the
ELAV family interact with an AU-rich element in the 39 UTRs
of several cytokine and other mRNAs and, at least in the case
of human cells, have been implicated in the control of cell
growth and differentiation, perhaps by influencing the degra-
dation of such messages (1, 7, 17, 21, 22, 24).
In this report, we show that the 36-kDa eCPE-binding pro-
tein and ElrA are the same protein. Although ElrA specifically
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interacts with RNAs harboring the eCPE both in vitro and in
vivo, an extensive series of experiments failed to demonstrate
that it has a function in cytoplasmic polyadenylation. However,
overexpression of a truncated ElrA in injected embryos results
in abnormal development beginning at the gastrula stage,
which suggests that it plays a role in early embryogenesis.
MATERIALS AND METHODS
UV cross-linking and immunoprecipitation. Oocyte and egg extracts were
prepared as described by McGrew and Richter (23) except that the oocytes were
first manually enucleated. UV cross-linking and immunoprecipitation were car-
ried out as described by Simon et al. (34) and Hake and Richter (12), respec-
tively. Constructs for an eCPE-containing Cl2 39 UTR (27 U’s) and eCPE-
lacking Cl2 39 UTRs (no U’s and 9 U’s) were described by Simon et al. (34). To
generate ElrA antiserum, the ElrA open reading frame was amplified by PCR,
inserted into the pET21D vector, and used to transform bacteria. Following
induction, ElrA protein was isolated from inclusion bodies and further purified
by sodium dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis (PAGE).
The ElrA band was then excised and injected into rabbits. To generate ElrB
antiserum, a PCR fragment that encodes amino acids 161 to 388 of ElrB was
inserted into pGEX-KG, and the truncated protein was expressed in induced
bacteria and purified on glutathione S-transferase (GST)–agarose (Pharmacia)
before injection into rabbits. To generate ElrD antiserum, the complete open
reading frame of ElrD was PCR amplified and inserted into pET15b, and bac-
terially expressed protein was purified on His-Bind columns (Novagen) before
injection into rabbits. For the UV cross-linking, 4 ml of oocyte or egg extract was
supplemented with 40,000 cpm of 32P-labeled RNA and 5 mg of heparin sulfate
per ml and irradiated with 254-nm light. The 40-ml mixture was then made to 48
ml with RNase A (1.67 mg/ml). Following an incubation of 20 min at 37°C,
protein was immunoprecipitated with anti-ElrA antibody attached to protein
A-Sepharose beads. The proteins were then fractionated on an SDS–10% poly-
acrylamide gel and visualized by phosphorimaging.
Analysis of ElrA expression during early embryo development. The prepara-
tion of oocytes and fertilized eggs was carried out as described by Hollinger and
Gorton (16), and embryo staging was done as specified by Nieuwkoop and Faber
(25). Total protein from oocytes, eggs, and embryos of different developmental
stages was extracted in XBK buffer (50 mM KCl, 0.1 mM CaCl2, 1 mM MgCl2,
10 mM K-HEPES [pH 7.6], 50 mM sucrose) plus protease inhibitors (10 mg each
of leupeptin, chymostatin, and pepstatin per ml), denatured in SDS sample
buffer, and resolved by SDS-PAGE (10% gel). Immunoblots were probed with
anti-ElrA antibody, and the resulting antigen-antibody complexes were detected
by chemiluminescence (ECL kit; Dupont).
Purification of His-ElrA and gel retardation assay. The coding region of ElrA
was inserted in frame behind a His tag at the BamHI site in the vector pPET15b
(Novagen). His-ElrA was expressed in bacteria following induction with isopro-
pylthiogalactopyranoside and purified by affinity chromatography over a His-
Bind metal chelating resin (Novagen) as instructed by the manufacturer. Eighty
nanograms of purified His-ElrA was first mixed with radiolabeled RNA probe in
10 ml of reaction mixture consisting of XBK buffer, 10 mM dithiothreitol, 0.5 mg
of tRNA, 1 mg of bovine serum albumin, 1 M urea (to aid in protein solubility),
and 2.5% glycerol and then incubated at room temperature for 20 min. Five
micrograms of heparin was then added, and the mixture was incubated for an
additional 10 min. The protein-RNA complexes were resolved by PAGE on a 5%
polyacrylamide gel containing 1 M urea and visualized by phosphorimaging.
Immunoprecipitation, RT-PCR, and RNase protection assays. Immunopre-
cipitation of protein-RNA complexes from cells was performed basically as
described by Steitz (41) and Levine et al. (21). Twenty oocytes or embryos were
homogenized in 500 ml of SM buffer (100 mM NaCl, 50 mM Tris-HCl [pH 7.4],
1 mM dithiothreitol, 1 U of RNasin, 1 ml of vanadyl ribonucleoside complex),
incubated with protein A–Sepharose CL-4B beads for at least an hour, and
centrifuged, and the supernatant was added to fresh antibody-bound protein
A-Sepharose beads. The RNA that was extracted from the immunoprecipitated
RNA-protein complexes was subjected to reverse transcription (RT)-PCR or
RNase protection as described by Simon et al. (36) or Gebauer et al. (8), re-
spectively. The specific primers used were 59 CCAAACTACTTTTGTCACTGT
GACAG 39 and 59 AATTCGGAAAGCAATTTC 39 for Cl2, 59 CCAAGCTTG
GCAAAGCATTTCATTTCAG 39 and 59 CGGGATCCCGGAGGGAGGTT
AAAGTCTGC 39 for ActR, 59 CAGATTGGTGCTGGATATGC 39 and 59
ACTGCCTTGATGACTCCTAG 39 for elongation factor 1a (EF-1a), 59 AAG
ACTGCAAGACGTCATGC 39 and 59 GTGCTGAACATGAGATAACG 39 for
ribosomal protein L1a (Rpl1a), 59 ATGCTGAGCAATACTACTGC 39 and 59
TCTGCATCTGCACTATCTGC 39 for a-tubulin (a-Tub), and 59 GACCGGAT
CCCTGCAGAAATTAGATAAAGG 39 and 59 GGAATTCCTATTATTTTAA
TTAACTTCAGG 39 for Cdk2.
Preparation of embryos for histology. Two His-tagged truncated ElrA con-
structs were made by PCR using pPET15b-ElrA as a template. For R1R2, T7
primer and 59 GCCAGATCTGGCAGCAAATTTTACTGTAATAGG 39 were
used. The resulting fragment was double digested with BamHI and BglII and
ligated into BamHI site of pPET15b. For R3, 59 GACGGATCCGGGTTGGTG
CATATTTGTCTAC 39 and T7 terminator primer were used. The resulting
fragment was digested with BamHI and ligated into the BamHI site of pPET15b.
Capped RNAs were in vitro synthesized by using a T7 message machine (Am-
bion) after templates were linearized with ClaI. Then 1 ng of RNA was injected
into each fertilized egg.
Embryos injected with RNA (two different preparations) were collected at
different stages and fixed, embedded in paraffin, sectioned, and stained as de-
scribed by Kelly et al. (18). Whole embryos were fixed in 4% paraformaldehyde
and 0.25% glutaraldehyde. After washing and dehydration, they were embedded
in paraffin and cut into 10-mm-thick sections. After the paraffin was removed, the
tissues were rehydrated and stained with hematoxylin and eosin Y.
Construction and purification of GST fusion protein. Because His-tagged
mutant ElrA proteins made in bacteria were insoluble, GST fusions were also
constructed. To construct GST fusion proteins, XhoI-BipI (blunt ended with
Klenow enzyme) fragments of His-tagged constructs were isolated and inserted
into XhoI and HindIII (blunt ended with Klenow enzyme) sites of vector pGEX-
KG. The fusion proteins were overexpressed in bacteria and were further puri-
fied by affinity chromatography on glutathione-agarose as described by Smith and
Johnson (37).
RESULTS
In previous experiments, we identified two Xenopus proteins
with molecular sizes of 36 and 45 kDa that were UV cross-
linked to the eCPEs of Cl1, Cl2, and ActR mRNAs (35, 36).
However, only the 36-kDa protein was cytoplasmic and there-
fore seemed the most likely one to be involved in mRNA
polyadenylation in embryos. Members of the ELG family en-
code proteins that bind U-rich sequences in cytokine mRNAs
similar to the eCPE and that range in size from 36 to 42 kDa
(1, 4, 21, 22). In Xenopus, several ELGs are expressed in the
oocyte and early embryo (10). To assess whether the 36- or
45-kDa proteins might be encoded by a member of this family,
we immunoprecipitated UV cross-linked RNA-protein com-
plexes with antisera specific for different members of this fam-
ily (Fig. 1). Among the antisera tested, only ElrA antiserum
(lane 5) immunoprecipitated a cross-linked protein from egg
extracts. However, the mobility of this cross-linked band did
not correspond precisely to either the 36- or 45-kDa protein;
instead, the band migrated somewhat heterogeneously be-
tween these two sizes. Although it is not unusual to see a slight
mobility change of a protein after immunoprecipitation (13),
we still did not know which of the two proteins the anti-ElrA
antibody recognized. However, because the remaining super-
natant following ElrA immunoprecipitation seemed to be
somewhat depleted of the 36-kDa protein (lane 9), we thought
that it was the most likely one to have reacted with the anti-
body. In addition, Western analysis of egg protein revealed
that only ElrA migrated with a size of 36 kDa; ElrB migrated
with a size of about 43 kDa, whereas ElrD was not detected.
Anti-ElrD antibody, however, is active because it reacts with
extract prepared from overexpressing bacteria (11).
To determine whether the 36-kDa UV cross-linked protein
was the one that reacted with anti-ElrA antibody, we took
advantage of our previous observation that only the 36-kDa
protein is cytoplasmic (36). Thus, extracts were prepared from
enucleated oocytes and used for UV cross-linking as described
above. As shown in Fig. 1B, the UV-cross-linked protein was
immunoprecipitated from eggs and enucleated oocytes (lanes 5
and 6), demonstrating that anti-ElrA antibody recognized the
36-kDa eCPEB. Thus, these initial experiments are consistent
with the possibility that ElrA and the 36-kDa eCPEB are the
same protein.
The Drosophila ELAV protein is a nuclear protein in post-
mitotic neurons, yet the 36-kDa protein is cytoplasmic. To con-
firm that ElrA is cytoplasmic, Xenopus oocytes were fraction-
ated into nuclear and cytoplasmic compartments and probed
on a Western blot with ElrA antiserum. Figure 1C shows that
ElrA was exclusively cytoplasmic. Similar results were obtained
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when radiolabeled ElrA was injected into oocytes and then
fractionated into nuclear and cytoplasmic compartments (11).
Cytoplasmic polyadenylation of maternal Cl2, Cl1, and ActR
mRNAs occurs in Xenopus embryos from 3 to 9 h after fertil-
ization. Although Northern blotting has previously shown that
ElrA mRNA is present during that time (10), we wanted to
ascertain whether ElrA protein was also present. A Western
blot shows that ElrA protein was present at roughly equal
levels in oocytes, eggs, and embryos at least up to the gastrula
stage (Fig. 2). The mobility of ElrA from egg extracts (lanes E)
was slightly lower than those from other development stages,
which may indicate a modification such as phosphorylation.
The observation that ElrA is cytoplasmic and is present in
oocytes and embryos is consistent with the idea that it may be
involved in cytoplasmic polyadenylation during embryo devel-
opment.
ElrA specifically recognizes the eCPE in vitro. To assess
whether ElrA DNA does indeed encode an eCPE-binding
protein, His-tagged ElrA protein was expressed in bacteria and
used in a gel retardation assay (Fig. 3A). Bacterially expressed
His-ElrA shifted the mobility of Cl2 39 UTR that contained an
eCPE (lane 2) but not one that lacked an eCPE (lane 4). To
demonstrate that the binding of ElrA to the eCPE was specific,
we also performed a competition UV cross-linking experiment
(Fig. 3B). Radiolabeled eCPE-containing Cl2 39 UTR plus
increasing amounts of unlabeled Cl2 39 UTR either containing
or lacking an eCPE (no U’s and nine U’s) was mixed with
His-ElrA and then subjected to UV cross-linking. While there
was no competition for binding of His-ElrA with Cl2 39 UTR
lacking an eCPE (no U’s [lanes 6 to 9] and nine U’s [lanes 11
to 13]), there was clear competition for binding with Cl2 39
UTR containing an eCPE (lanes 2 to 5). Thus, ElrA has a
strong binding preference for eCPE-containing RNA.
We also performed binding experiments using homori-
bopolymers as competitors. Figure 3C shows that only poly(U)
(lanes 2 to 4), not poly(A) (lanes 5 to 7) or poly(C) (lanes 8 to
10), competed with Cl2 RNA for ElrA binding. This result
further demonstrated that ElrA binds directly to poly(U).
Other members of the ELAV family, such as Hel-N1 (the
human homolog of ElrB) and HuD (the human homolog of
ElrD), are known to bind to AU-rich elements (4, 6). To rule
out the possibility that ElrA binds to Cl2 RNA simply because
of its affinity to AU-rich sequences, we performed a gel retar-
dation assay using the histone B4 39 UTR (Fig. 3A, lanes 5 to
8), which contains an AU-rich sequence composed of a matu-
ration-type CPE. The result shows that ElrA did not alter the
mobility of the B4 39 UTR irrespective of whether it contained
an AU-rich CPE. These results indicate that ElrA encodes an
eCPE-binding protein and that the binding of ElrA to its target
sequence is selective and sequence specific.
ElrA binds eCPE-containing mRNA in vivo. We next wanted
to determine whether ElrA interacts with the eCPE in vivo.
To do so, we conducted immunoprecipitation experiments
in which the RNA component of specific mRNPs can be as-
sessed. Protein-RNA complexes from oocytes or 6-h embryos
were immunoselected with an anti-ElrA antibody and then
subjected to RNA extraction and RT-PCR using primers spe-
cific for Cl2 and ActR mRNAs (Fig. 4). As expected, Cl2 and
ActR mRNAs were both detected in ElrA-RNA complexes in
oocytes and embryos (lanes 1 and 3). However, EF-1a, Rpl1a,
a-Tub, and Cdk2 mRNAs, all of which contain no eCPE, were
not immunoselected with the antibody.
To test whether the in vivo interaction of ElrA and mRNA
was eCPE dependent, we injected a Cl2 39 UTR containing or
FIG. 1. Identification of ElrA as the 36-kDa eCPE-binding protein. (A)
Radiolabeled Cl2 39 UTR was UV cross-linked with egg extract protein (lane 1)
and subjected to immunoprecipitation with protein A-Sepharose only (lanes 2
and 6) or protein A-Sepharose complexed with anti-ElrB (lanes 3 and 7), anti-
ElrD (lanes 4 and 8), and anti-ElrA (lanes 5 and 9) antibodies. Cross-linked
proteins in the immunoprecipitate pellet (lanes 2 to 5) and 1/20 supernatant (sup;
lanes 6 to 9) are shown along with Western blots of egg protein probed with
anti-ElrB (lane 10), anti-ElrD (lane 11), and anti-ElrA (lane 12) antibodies. (B)
Radiolabeled Cl2 39 UTR was UV cross-linked with either egg extract protein
(E; lane 1) or enucleated oocyte cytoplasmic protein (C; lane 2) and subjected to
immunoprecipitation with protein A-Sepharose only (lanes 3, 4, 7, and 8) or
protein A-Sepharose complexed with an anti-ElrA antibody (lanes 5, 6, 9, and
10). As in panel A, cross-linked proteins in the immunoprecipitate pellet (lanes
3 to 6) and 1/20 supernatant (lanes 7 to 10) are shown. (C). Oocytes were
manually dissected into nuclear (GV; lane 1) and cytoplasmic (Cyto; lane 2)
compartments and probed on a Western blot with anti-ElrA. Total oocyte pro-
tein was also analyzed (lane 3).
FIG. 2. ElrA expression during early embryo development. About one oo-
cyte or embryo equivalent was applied to each lane of a Western blot probed with
an anti-ElrA antibody. Oocyte (O) and egg (E) proteins were also analyzed.
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lacking the eCPE into oocytes or fertilized eggs. After a 3-h
incubation, the RNA-protein complexes were immunoselected
with an anti-ElrA antibody; this was followed by RNA extrac-
tion and detection of Cl2 RNA by RNase protection (Fig. 5A).
The results show that only the eCPE-containing Cl2 RNA
could be detected in the immunoselected RNA-ElrA com-
plexes from either oocytes or embryos (lanes 6 and 12). A
similar result was obtained when the ActR 39 UTR was in-
jected (Fig. 5B). That is, only the RNA containing the eCPE
could be immunoselected with the anti-ElrA antibody (lane 5).
These results indicate that ElrA binds in vivo at least two
eCPE-containing mRNAs through the eCPE.
ElrA in early development. Although ElrA binds the eCPE
in vivo, we could not assign a function for the protein in cyto-
plasmic polyadenylation, primarily because eCPE-mediated
polyadenylation in extracts is very weak (see Discussion). How-
ever, we have examined whether ElrA could play a role in
development by the expression of a potential dominant nega-
tive form of the protein. As stated earlier, ElrA is comprised of
three RRMs plus a hinge region (Fig. 6). This arrangement
results in two separate RNA-binding domains, one composed
of RRMs 1 and 2 and the other consisting of RRM 3. With a
human homolog, HuD (ElrD), RRMs 1 and 2 are responsible
for binding to the AU-rich RNA sequences (4), although an-
other study with Hel-N1 (ElrB) shows that RRM 3 is respon-
sible for specific RNA binding (21). To assess which domain in
ElrA binds the eCPE, we have expressed ElrA RRMs 1 and 2,
as well as RRM 3, as GST-tagged fusion proteins in bacteria.
When used in RNA gel shift assays, only GST-RRM 112
bound RNA in an eCPE-dependent manner (Fig. 6; compare
lanes 2 to 4 with lanes 6 to 8). Presumably, RRM 3 either binds
to another RNA sequence or may be used in protein-protein
interactions. We noted, however, that in this experiment,
GST–wild-type ElrA bound some eCPE-lacking RNA, which
we believe was due to the large amount of expressed protein
added to the gel shift reaction.
Next, we injected mRNAs encoding wild-type ElrA, ElrA-
RRM 112, and ElrA-RRM 3 into fertilized eggs and examined
the morphology of developing embryos at two subsequent
times. When assessed in whole mount, only embryos derived
from eggs injected with ElrA-RRM 112 exhibited a “mush-
room cap” appearance when their noninjected siblings had
reached stage 13 (compare Fig. 7a and b). When noninjected
controls were stage 30 tadpoles (Fig. 7c), the embryos that had
received ElrA-RRM 112 mRNA were somewhat amorphous
in appearance (Fig. 7d).
An examination of tissue sections of ElrA-RRM 112
mRNA-injected embryos reveals that they were normal up to
FIG. 3. In vitro interaction between ElrA and eCPE. (A) Gel mobility shift
assay. Eighty nanograms of bacterially expressed His-ElrA was mixed with ra-
diolabeled Cl2 39 UTR that either contained (lane 2) or lacked (lane 4) an eCPE
or with radiolabeled B4 39 UTR that either contained (lane 6) or lacked (lane 8)
a maturation-type CPE. No protein was added in the odd-numbered lanes. The
sequences for the eCPE of Cl2 and the CPE of B4 RNAs are shown. (B) UV
cross-linking competition assay. Eighty nanograms of His-ElrA was UV cross-
linked with radiolabeled Cl2 39 UTR (lanes 1 and 10) in the presence of an excess
amount of unlabeled Cl2 39 UTR that either contained (lanes 2 to 5) or lacked
(no U’s [lanes 6 to 9] and nine U’s [lanes 11 to 13]) an eCPE. The molar ratios
of the RNAs are indicated. (C) UV cross-linking competition assay. Eighty
nanograms of His-ElrA was UV cross-linked with radiolabeled Cl2 39 UTR (lane
1) in the presence of an excess amount of unlabeled poly(U) (lanes 2 to 4),
poly(A) (lanes 5 to 7), or poly(C) (lanes 8 to 10).
FIG. 4. In vivo interaction of ElrA and eCPE-containing RNA. Cell extracts
from about 10 oocytes (oo) or embryos (em) were immunoprecipitated with
either an anti-ElrA antibody (Ab.) (lanes 1 and 3) or preimmune serum (lanes 2
and 4), and the RNA that was coimmunoprecipitated was detected by RT-PCR.
Two eCPE-containing RNAs (Cl2 and ActR) and four eCPE-lacking RNAs
(EF1-a, Rpl1a, a-Tub, and Cdk2) were analyzed.
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stage 9 (compare Fig. 8a and d), but by stage 11, they began to
show signs of abnormal gastrulation (compare Fig. 8b and e).
By stage 13, the injected embryos exhibited a clear exogastru-
lation phenotype (compare Fig. 8c and f).
Using this exogastrulation phenotype as a measure, we com-
pared the morphologies of embryos injected with mRNA en-
coding wild-type and truncated ElrA proteins (Table 1). While
wild-type ElrA mRNA injection elicited no phenotype, and
ElrA-RRM 3 mRNA injection induced exogastrulation in only
3% of embryos, ElrA-RRM 112 mRNA injection resulted in
exogastrulation 70% of the time. Thus, ElrA-RRM 112 prob-
ably acts as a dominant negative mutation by binding mRNA,
which suggests that ElrA has an important function during
Xenopus gastrulation.
DISCUSSION
Although cytoplasmic polyadenylation of maternal mRNA is
widespread among metazoans, an analysis of the one known
factor that regulates this process has come exclusively from
studies of Xenopus and the mouse. During oocyte maturation
in both species, the 62-kDa CPE-binding protein (CPEB) in-
teracts with the UUUUUAU-type CPE (9, 12) and at least in
the frog (the only system in which it has been tested), it is
essential for cytoplasmic polyadenylation. This conclusion is
based on two observations. First, immunodepletion of CPEB
from egg extracts destroys their ability to polyadenylate exog-
enous RNA. However, supplementation of this depleted ex-
tract with CPEB synthesized either in vitro or in bacteria re-
stores polyadenylation (12, 14). Second, the injection of a
CPEB antibody into oocytes prevents polyadenylation in vivo
(40). CPEB, which is also conserved among several inverte-
brates (3, 20, 43), is phosphorylated during maturation (12,
30), although the extent to which this is important for activity
of the protein is unclear (5). The specificity of the interaction
of CPEB for RNA resides in three parts of the protein: the two
RRMs and a cysteine-histidine region that coordinates a metal
ion (15).
Because CPEB is destroyed late in maturation and is almost
undetectable in the early cleavage stages (12), it seemed quite
unlikely to regulate polyadenylation in the embryo. Moreover,
UV cross-linking experiments revealed that two smaller
proteins with sizes of 36 and 45 kDa interacted with the
poly(U)12–27 eCPE. In this report, we show that the 36-kDa
species, the only one that is cytoplasmic, is ElrA (10). The two
proteins have the same molecular size, antibody directed
FIG. 5. In vivo interaction of ElrA and RNA requires an eCPE. (A) The 39 UTR of Cl2 either containing (lanes 6, 9, 12, and 15) or lacking (lanes 7, 10, 13, and
16) an eCPE was injected into oocytes or fertilized eggs. Cell extracts were then prepared from these oocytes and resulting embryos, as well as from uninjected oocytes
and eggs (lanes 5, 8, 11, and 14), which were used for mRNP immunoprecipitation. RNA was extracted from material immunoprecipitated with either an anti-ElrA
or anti-ElrB antibody and was analyzed by RNase protection. Lane 1, probe alone; lane 2, probe digested with RNase A; lane 3, protected product from in
vitro-synthesized RNA that contained an eCPE; lane 4, protected product from in vitro-synthesized RNA that lacked an eCPE. (B) RNase protection of injected ActR
39 UTR coimmunoprecipitated with an anti-ElrA antibody. Lanes 1 to 4 are the same as in panel A except that only fertilized eggs were injected.
FIG. 6. RNA binding of truncated ElrA proteins. (A) Diagram of GST-
tagged fusion proteins made in bacteria. The locations of RRMs are indicated.
wt, wild type. (B) Gel shift analysis of ElrA proteins. Wild-type, ElrA-RRM 112,
and ElrA-RRM 3 proteins were used in a gel shift assay with Cl2 RNA either
containing (lanes 2 to 4, respectively) or lacking (lanes 6 to 8, respectively) an
eCPE. Lanes 1 and 5 show free probe without protein.
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against ElrA immunoprecipitates the 36-kDa protein, and the
two proteins show the same binding specificity for the eCPE
both in vitro and in vivo.
Using the analysis of CPEB activity in cytoplasmic polyade-
nylation during maturation as a paradigm, we have attempted
several experiments to assess the possible function of ElrA in
embryonic polyadenylation. First, although egg extracts faith-
fully and vigorously polyadenylate RNAs carrying the matura-
tion-type CPE, they only weakly polyadenylate RNAs with an
embryonic-type CPE. This is the case with embryo extracts as
well and occurs irrespective of whether the RNA also contains
a masking element (44). Because of this, we could not assess
the effects of ElrA immunodepletion on polyadenylation. Al-
though we do not know why embryonic polyadenylation is so
poor, it is not due to the degradation of ElrA (44). A second
assay that we used successfully in the examination of CPEB
activity was antibody injection. In that case, we were able to
affinity purify antibody that still (presumably) bound the pro-
tein avidly in vivo. With ElrA, we could not purify antibody
with a sufficiently high affinity and/or titer to perform a similar
experiment (44). Third, we injected truncated ElrA proteins
made in bacteria into fertilized eggs with the idea that they
might block polyadenylation in vivo. This did not occur, which
could be due to a number of possibilities, including aberrant
folding of the protein or perhaps a requirement that it be in
excess over endogenous ElrA beyond what we could inject.
Fourth, although injected mRNA encoding a truncated ElrA
protein induced a gastrulation-defective phenotype, it did not
inhibit polyadenylation of endogenous as well as injected Cl2
or activin receptor mRNAs (44) (see below). However, be-
cause the abnormal phenotype was observed only beginning at
stage 11, polyadenylation, at least of our test RNAs, had al-
ready taken place. Thus, while our data do not support a role
for ElrA in cytoplasmic polyadenylation, neither do they dis-
prove it. Indeed, given that ElrA binds the eCPE in vivo, one
may still surmise that it is involved in this process.
The injection of mRNA encoding ElrA RRMs 1 and 2 con-
sistently produced an exogastrulation phenotype (Table 1).
Because these two RRMs are the regions that interact with the
eCPE (Fig. 6), we believe that they bound an mRNA(s) in vivo
and inhibited its expression. The exogastrulation phenotype
implies a defect in cell adhesion. In Drosophila, mutations in
elav affect the accumulation of a neuron-specific form of neu-
roglian, a cell adhesion molecule (19). While we do not know
which mRNA(s) was thus affected, we have examined two cell
adhesion molecules that are thought to be involved in gastru-
lation, fibronectin and integrin b1 (38). Both RNAs contain a
putative eCPE in their 39 UTRs, and fibronectin mRNA is
detected in ElrA coimmunoprecipitation experiments (44).
However, Western blots indicate that both fibronectin and
integrin b1 levels were unaffected by ElrA-RRM 112 mRNA
injection (44). Thus, the aberrant expression of other RNAs is
probably the cause of exogastrulation. We should also note
that an exogastrulation phenotype can be induced nonspecifi-
FIG. 7. Morphology of mRNA-injected embryos. Noninjected (a and c) and ElrA-RRM 112 mRNA-injected (b and d) eggs were examined in whole mount when
the embryos reached stage 13 (a and b) or stage 30 (c and d).
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cally by RNA injection (31). However, in this study (Table 1),
only transcripts encoding RRMs 1 and 2 did so, which strongly
indicates that this was a specific response.
An additional consideration of the activity of ElrA should
include RNA degradation. Members of this protein family do
interact with the AUUUA degradation sequence (2, 4, 24).
However, we should point out that the minimum number of
uridine residues that can promote cytoplasmic polyadenylation
in embryos is 12, which strongly correlates with the number of
uridines required for binding of the 36-kDa protein/ElrA (34,
35). Thus, if ElrA has a function related to mRNA degradation
in early development, it would probably have to do so via this
FIG. 8. Analysis of sectioned material from mRNA-injected embryos. Noninjected (a to c) and ElrA-RRM 112 mRNA-injected (d to f) eggs were examined when
the embryos had reached stages 9 (a and d), 11 (b and e), and 13 (c and f). The embryos were paraffin embedded, sectioned, and stained with hematoxylin and eosin Y.
TABLE 1. Assessment of exogastrulation following mRNA injection
Agent injected No. of embryosinjecteda
No. of
exogastrulaeb
% Exogastru-
lation
None 128 1 0.8
Water 83 0 0
RNAc
Wild-type ElrA 74 0 0
ElrA-RRM 112 139 98 70.5
ElrA-RRM 3 65 2 3.1
a Only those embryos that survived at least 4 h after injection were counted.
b Embryos were examined at stage 13.
c RNA concentration was 0.1 mg/ml; about 10 nl was injected per egg.
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sequence, which has not previously been identified with this
activity.
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